Schedule of Shareholder Equity Warrants Outstanding (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
shares
| |
| Equity [Abstract] | |
| Shares outstanding, beginning | 666,667 |
| Shares issued | 5,631,404 |
| Shares exercised | |
| Shares tendered | |
| Shares expired | |
| Shares outstanding, ending | 6,298,071 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments tendered. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|